Cover Image
QR Code

Drug update: new drug information from the publishers of MPR. Zelapar reduces 'off time' in Parkinson's.

Published in:Clinical Advisor Vol. 10; no. 2; pp. 23 - 25
Format: pictorial Journal Article
Published: Haymarket Media, Inc. 2007 Feb
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106261682&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106261682
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15247317
        Z1J
      jtl: Clinical Advisor
      issn: 15247317
      maglogo: N
    pubinfo:
      dt: 2007 Feb
      vid: 10
      iid: 2
      pid: 1385
      pub: Haymarket Media, Inc.
      place: New York, New York
    artinfo:
      ui:
        106261682
        106261682
        2009520098
        106261682
      ppf: 23
      ppct: 2
      formats:
      tig:
        atl: Drug update: new drug information from the publishers of MPR. Zelapar reduces 'off time' in Parkinson's.
      aug:
      sug:
        subj:
          Parkinson Disease Drug Therapy
          Selegiline Therapeutic Use
          Administration, Sublingual
          Clinical Trials
          Selegiline Administration and Dosage
          Selegiline Contraindications
          Selegiline Pharmacodynamics
      pubtype: Periodical
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N